Analyst Price Targets — CRMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| March 6, 2026 8:13 pm | Roanna Ruiz | Leerink Partners | $13.00 | $6.46 | StreetInsider | CorMedix (CRMD) PT Lowered to $13 at Leerink Partners |
| January 23, 2026 11:08 am | — | H.C. Wainwright | $13.00 | $7.44 | TheFly | CorMedix price target lowered to $13 from $18 at H.C. Wainwright |
| January 21, 2026 11:34 am | — | RBC Capital | $13.00 | $6.88 | TheFly | CorMedix price target lowered to $13 from $22 at RBC Capital |
| January 8, 2026 5:42 pm | — | Truist Financial | $16.00 | $7.44 | TheFly | CorMedix price target lowered to $16 from $20 at Truist |
| October 21, 2025 11:08 am | Gregory Renza | RBC Capital | $22.00 | $12.16 | TheFly | CorMedix price target raised to $22 from $21 at RBC Capital |
| August 8, 2025 10:03 am | Brandon Folkes | H.C. Wainwright | $17.00 | $10.33 | TheFly | CorMedix price target lowered to $17 from $20 at H.C. Wainwright |
| March 13, 2024 6:21 am | Gregory Renza | RBC Capital | $9.00 | $3.90 | StreetInsider | CorMedix (CRMD) PT Lowered to $9 at RBC Capital |
Latest News for CRMD
Assenagon Asset Management S.A. Increases Stock Holdings in CorMedix Inc $CRMD
Assenagon Asset Management S.A. increased its stake in shares of CorMedix Inc (NASDAQ: CRMD) by 35.0% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned 302,508 shares of the company's stock after purchasing an additional 78,447 shares during the quarter. Assenagon Asset Management
CorMedix Inc. (CRMD) Q4 2025 Earnings Call Transcript
CorMedix Inc. (CRMD) Q4 2025 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CRMD.
U.S. House Trading
No House trades found for CRMD.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.